Counterpath (CPAH) Reports Q2 EPS of $0.01
Tweet
Share
E-mailGet Alerts CPAH Hot Sheet
Join SI Premium – FREE
Counterpath (NASDAQ: CPAH) reported Q2 EPS of $0.01, versus ($0.11) reported last year. Revenue for the quarter came in at $3.4 million, versus $2.8 million reported last year.
For earnings history and earnings-related data on Counterpath (CPAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carlyle sees improving exit conditions for "good companies"
- Brink's (BCO) Tops Q2 EPS by 8c ; Offers Guidance
- Immuneering Corporation (IMRX) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
